118 related articles for article (PubMed ID: 37254542)
1. E7386 is not a Specific CBP/β-Catenin Antagonist.
Higuchi Y; Nguyen C; Chimge NO; Ouyang C; Teo JL; Kahn M
Curr Mol Pharmacol; 2024; 17(1):e290523217409. PubMed ID: 37254542
[TBL] [Abstract][Full Text] [Related]
2. Taking the road less traveled - the therapeutic potential of CBP/β-catenin antagonists.
Kahn M
Expert Opin Ther Targets; 2021 Sep; 25(9):701-719. PubMed ID: 34633266
[TBL] [Abstract][Full Text] [Related]
3. E7386, a Selective Inhibitor of the Interaction between β-Catenin and CBP, Exerts Antitumor Activity in Tumor Models with Activated Canonical Wnt Signaling.
Yamada K; Hori Y; Inoue S; Yamamoto Y; Iso K; Kamiyama H; Yamaguchi A; Kimura T; Uesugi M; Ito J; Matsuki M; Nakamoto K; Harada H; Yoneda N; Takemura A; Kushida I; Wakayama N; Kubara K; Kato Y; Semba T; Yokoi A; Matsukura M; Odagami T; Iwata M; Tsuruoka A; Uenaka T; Matsui J; Matsushima T; Nomoto K; Kouji H; Owa T; Funahashi Y; Ozawa Y
Cancer Res; 2021 Feb; 81(4):1052-1062. PubMed ID: 33408116
[TBL] [Abstract][Full Text] [Related]
4. NF-κB suppression synergizes with E7386, an inhibitor of CBP/β-catenin interaction, to block proliferation of patient-derived colon cancer spheroids.
Kanda Y; Ohata H; Miyazaki T; Sakai H; Mori Y; Shiokawa D; Yokoi A; Owa T; Ochiai A; Okamoto K
Biochem Biophys Res Commun; 2022 Jan; 586():93-99. PubMed ID: 34837838
[TBL] [Abstract][Full Text] [Related]
5. Functional and genomic analyses reveal therapeutic potential of targeting β-catenin/CBP activity in head and neck cancer.
Kartha VK; Alamoud KA; Sadykov K; Nguyen BC; Laroche F; Feng H; Lee J; Pai SI; Varelas X; Egloff AM; Snyder-Cappione JE; Belkina AC; Bais MV; Monti S; Kukuruzinska MA
Genome Med; 2018 Jul; 10(1):54. PubMed ID: 30029671
[TBL] [Abstract][Full Text] [Related]
6. The Mode of Stem Cell Division Is Dependent on the Differential Interaction of β-Catenin with the Kat3 Coactivators CBP or p300.
Lukaszewicz AI; Nguyen C; Melendez E; Lin DP; Teo JL; Lai KKY; Huttner WB; Shi SH; Kahn M
Cancers (Basel); 2019 Jul; 11(7):. PubMed ID: 31324005
[TBL] [Abstract][Full Text] [Related]
7. β-Catenin/CBP inhibition alters epidermal growth factor receptor fucosylation status in oral squamous cell carcinoma.
Chandler KB; Alamoud KA; Stahl VL; Nguyen BC; Kartha VK; Bais MV; Nomoto K; Owa T; Monti S; Kukuruzinska MA; Costello CE
Mol Omics; 2020 Jun; 16(3):195-209. PubMed ID: 32203567
[TBL] [Abstract][Full Text] [Related]
8. The novel inhibitor PRI-724 for Wnt/β-catenin/CBP signaling ameliorates bleomycin-induced pulmonary fibrosis in mice.
Okazaki H; Sato S; Koyama K; Morizumi S; Abe S; Azuma M; Chen Y; Goto H; Aono Y; Ogawa H; Kagawa K; Nishimura H; Kawano H; Toyoda Y; Uehara H; Kouji H; Nishioka Y
Exp Lung Res; 2019 Sep; 45(7):188-199. PubMed ID: 31298961
[No Abstract] [Full Text] [Related]
9. Therapeutic targeting of CBP/β-catenin signaling reduces cancer stem-like population and synergistically suppresses growth of EBV-positive nasopharyngeal carcinoma cells with cisplatin.
Chan KC; Chan LS; Ip JC; Lo C; Yip TT; Ngan RK; Wong RN; Lo KW; Ng WT; Lee AW; Tsao GS; Kahn M; Lung ML; Mak NK
Sci Rep; 2015 Apr; 5():9979. PubMed ID: 25897700
[TBL] [Abstract][Full Text] [Related]
10. Disruption of β-catenin/CBP signaling inhibits human airway epithelial-mesenchymal transition and repair.
Moheimani F; Roth HM; Cross J; Reid AT; Shaheen F; Warner SM; Hirota JA; Kicic A; Hallstrand TS; Kahn M; Stick SM; Hansbro PM; Hackett TL; Knight DA
Int J Biochem Cell Biol; 2015 Nov; 68():59-69. PubMed ID: 26315281
[TBL] [Abstract][Full Text] [Related]
11. Interactions between β-catenin and transforming growth factor-β signaling pathways mediate epithelial-mesenchymal transition and are dependent on the transcriptional co-activator cAMP-response element-binding protein (CREB)-binding protein (CBP).
Zhou B; Liu Y; Kahn M; Ann DK; Han A; Wang H; Nguyen C; Flodby P; Zhong Q; Krishnaveni MS; Liebler JM; Minoo P; Crandall ED; Borok Z
J Biol Chem; 2012 Mar; 287(10):7026-38. PubMed ID: 22241478
[TBL] [Abstract][Full Text] [Related]
12. Specific Direct Small Molecule p300/β-Catenin Antagonists Maintain Stem Cell Potency.
Higuchi Y; Nguyen C; Yasuda SY; McMillan M; Hasegawa K; Kahn M
Curr Mol Pharmacol; 2016; 9(3):272-279. PubMed ID: 26008738
[TBL] [Abstract][Full Text] [Related]
13. Differential Kat3 Coactivator Usage Regulates Brain Metabolism and Neuronal Differentiation.
Poku EK; Ono M; Higuchi Y; Chea J; Melendez E; Teo JL; Nguyen C; Chimge NO; Kahn M
Curr Mol Pharmacol; 2024; 17(1):e170823219875. PubMed ID: 37594155
[TBL] [Abstract][Full Text] [Related]
14. The gamma catenin/CBP complex maintains survivin transcription in β-catenin deficient/depleted cancer cells.
Kim YM; Ma H; Oehler VG; Gang EJ; Nguyen C; Masiello D; Liu H; Zhao Y; Radich J; Kahn M
Curr Cancer Drug Targets; 2011 Feb; 11(2):213-25. PubMed ID: 21158719
[TBL] [Abstract][Full Text] [Related]
15. Differentiation Therapy Targeting the β-Catenin/CBP Interaction in Pancreatic Cancer.
Manegold P; Lai KKY; Wu Y; Teo JL; Lenz HJ; Genyk YS; Pandol SJ; Wu K; Lin DP; Chen Y; Nguyen C; Zhao Y; Kahn M
Cancers (Basel); 2018 Mar; 10(4):. PubMed ID: 29596326
[TBL] [Abstract][Full Text] [Related]
16. β-catenin/CBP activation of mTORC1 signaling promotes partial epithelial-mesenchymal states in head and neck cancer.
Reed ER; Jankowski SA; Spinella AJ; Noonan V; Haddad R; Nomoto K; Matsui J; Bais MV; Varelas X; Kukuruzinska MA; Monti S
Transl Res; 2023 Oct; 260():46-60. PubMed ID: 37353110
[TBL] [Abstract][Full Text] [Related]
17. Determination of the Role of CBP- and p300-Mediated Wnt Signaling on Colonic Cells.
Bordonaro M; Lazarova DL
JMIR Res Protoc; 2016 May; 5(2):e66. PubMed ID: 27177606
[TBL] [Abstract][Full Text] [Related]
18. Characterization of Imatinib Resistant CML Leukemic Stem/Initiating Cells and Their Sensitivity to CBP/Catenin Antagonists.
Zhao Y; Wu K; Wu Y; Melendez E; Smbatyan G; Massiello D; Kahn M
Curr Mol Pharmacol; 2018; 11(2):113-121. PubMed ID: 28933312
[TBL] [Abstract][Full Text] [Related]
19. Regulation of Human Airway Epithelial Tissue Stem Cell Differentiation by β-Catenin, P300, and CBP.
Malleske DT; Hayes D; Lallier SW; Hill CL; Reynolds SD
Stem Cells; 2018 Dec; 36(12):1905-1916. PubMed ID: 30171668
[TBL] [Abstract][Full Text] [Related]
20. Inhibition of Cyclic Adenosine Monophosphate (cAMP)-response Element-binding Protein (CREB)-binding Protein (CBP)/β-Catenin Reduces Liver Fibrosis in Mice.
Osawa Y; Oboki K; Imamura J; Kojika E; Hayashi Y; Hishima T; Saibara T; Shibasaki F; Kohara M; Kimura K
EBioMedicine; 2015 Nov; 2(11):1751-8. PubMed ID: 26870800
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
